Clal Insurance Enterprises (CLIS) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
10 Nov, 2026Executive summary
2024 comprehensive income after tax reached NIS 956m, up NIS 651m YoY; performance reflected the strategic turnaround and contributions across insurance, savings and credit cards.
Strategy centers on growing core insurance, expanding MAX and combining capabilities through tailored financial products and shared distribution.
Financial highlights
2024 comprehensive income was NIS 956m; 2019–2024 premiums grew 40% to NIS 26.7b.
AUM stood at NIS 369b, shareholders’ equity at NIS 9.45b, and dividends distributed at NIS 100m.
2024 improvement included higher investment income at MAX: ~NIS 614m vs ~NIS 192m in 2023; 2023 also included a one-time ~NIS 220m acquisition provision.
Outlook and guidance
Medium-term 2027 targets: comprehensive income NIS 1.3–1.6b, ROE 12%–15%, dividends ~NIS 200m, and AUM NIS 420–460b.
Equity targets are ~NIS 11b by Dec. 2026 and NIS 12b by Dec. 2027; targets assume no additional capital raising and are adjusted to IFRS 17 and IFRS 9.
Latest events from Clal Insurance Enterprises
- Markets and P&C gains restored profitability, while health reserves and war uncertainty weighed.CLIS
Q1 2024 - H1 returned to profit on stronger underwriting and card results despite weak markets.CLIS
Q2 2024 - 9M comprehensive income reached NIS 596m, supported by stronger investment returns and underwriting.CLIS
Q3 2024 - Q1 earnings rose on stronger underwriting and Max, amid market and war-related uncertainty.CLIS
Q1 2025 - H1 core income rose modestly as strong insurance results met Q2 softness and a VAT provision.CLIS
Q2 2025 - 9M earnings and AUM grew, with results absorbing a one-off VAT provision.CLIS
Q3 2025 - Core income rose 12%; 2025 dividend reached NIS 400M.CLIS
Q4 2025 - Core income rose 13% as insurance and savings growth lifted Q1 results.CLIS
Q1 2026 - H1 earnings and AUM grew, alongside NIS 200M buyback and dividend plans.CLIS
Q2 2026